Changing Drug Markets Under New Intellectual Property Regimes
The View From Central America
Bibliographic Data
| ID | 11030676 |
|---|---|
| Authors | Angelina Snodgrass Godoy (Angelina Snodgrass Godoy is with the Center for Human Rights and Alejandro Cerón is with the Department of Anthropology, University of Washington, Seattle. Alejandro Cerón is also with the Instituto de Salud Incluyente, San Lucas, Guatemala.), Alejandro Cerón (0000-0002-9031-4243, Angelina Snodgrass Godoy is with the Center for Human Rights and Alejandro Cerón is with the Department of Anthropology, University of Washington, Seattle. Alejandro Cerón is also with the Instituto de Salud Incluyente, San Lucas, Guatemala.) |
| Year | 2011 |
| Volume | 101 |
| Issue | 7 |
| Pages | 1186-1191 |
| Publication date | 2011-07-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | American Journal of Public Health (JOURNAL) |
| Journal identifiers | ISSN: 0090-0036 • E-ISSN: 1541-0048 |
| Publisher | American Public Health Association (PUBLISHER • US) |
| DOI | 10.2105/ajph.2010.300071 |
| PMID | 21566033 |
| PMCID | PMC3110216 |
| OpenAlex | W2109290624 |
| Language | EN |
| Citations received | 2 |
| References cited | 2 |
The intellectual property rules inscribed in the Central American Free Trade Agreement have generated concern about access to medicines. We examined the implementation of the new intellectual property regime by tracking the policies and practices in place across 4 Central American countries. Although all 4 were responding to the same requirements under the agreement, their implementation of intellectual property rules differed. Not only were institutional practices different, but the lists of drugs to which intellectual property protection was applied varied in both volume and content. We also found that even without the influence of intellectual property, drug pricing in the region was often unpredictable and that lower cost was not the only motivation driving governments' purchasing decisions
Actuarial science · Business · Economics · Inscribed figure · Intellectual property · International trade · Law and economics · Political science · Property (philosophy) · Public economics · Purchasing · Intellectual Property and Patents · Law · Marketing · Pharmaceutical Economics and Policy
| Unique citing works | 2 |
|---|---|
| Citations per year | 0.18 |
| Citation span | 2015 - 2016 (2) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 2 |